Phio Pharmaceuticals Completes Enrollment In Second Cohort In Phase 1b Dose-Escalating Clinical Study

Benzinga11/19 20:48

Phio Pharmaceuticals Announces Completion of Enrollment in Second Cohort in Phase 1b Dose-Escalating Clinical Study

newsfile11/19 20:45

Phio Pharma Shares Are Trading Higher. The Company Reported Q3 Financial Results.

Benzinga11/15 21:36

Phio Pharma Q3 2024 GAAP EPS $(1.54) May Not Be Comparable To $(4.14) Estimate

Benzinga11/15 06:50

フィオ・ファーマシューティカルズ | 10-Q：Q3 2024 四半期報告書

SEC11/15 05:54

Phio Pharmaceuticals Announces Upcoming Presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Phio Pharmaceuticals 10/24 12:00